BioRestorative Therapies, Inc.
News
Equities Analysts Offer Predictions for BioRestorative Therapies, Inc.'s Q3 2024 Earnings (NASDAQ:BRTX)
Ticker Report BioRestorative Therapies, Inc. (NASDAQ:BRTX - Free Report) - Research analysts at Roth Capital upped their Q3 2024 earnings per share estimates for BioRestorative Therapies in a report released on...\n more…
BioRestorative Therapies, Inc. Expected to Post FY2027 Earnings of $2.57 Per Share (NASDAQ:BRTX)
Ticker Report BioRestorative Therapies, Inc. (NASDAQ:BRTX - Free Report) - Research analysts at Roth Capital decreased their FY2027 earnings per share estimates for shares of BioRestorative Therapies in a research...\n more…
FY2027 EPS Estimates for BioRestorative Therapies, Inc. Reduced by Roth Capital (NASDAQ:BRTX)
Zolmax BioRestorative Therapies, Inc. (NASDAQ:BRTX - Free Report) - Analysts at Roth Capital reduced their FY2027 earnings estimates for shares of BioRestorative Therapies in a note issued to investors on...\n more…
BioRestorative Therapies (NASDAQ:BRTX) Releases Earnings Results, Beats Expectations By $0.06 EPS
Zolmax BioRestorative Therapies (NASDAQ:BRTX - Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.50) earnings per share for the quarter, topping analysts...\n more…
BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q2 2024
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nBRTX stock results show that BioRestorative Therapies beat analyst estimates for earnings per share and beat on revenue for the second...\n more…
Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Tops Revenue Estimates
Zacks Investment Research Biorestorative Therapies, Inc. (BRTX) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to loss of $0.77 per share a year ago...\n more…